Top compounds associated with response to SCRT1


Feature Type Standardized
Nominal ANOVA
mRNA manumycin A CTRPv2 pan-cancer AAC 0.21 2e-09
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.24 6e-08
mRNA lomeguatrib CTRPv2 pan-cancer AAC 0.23 8e-08
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.22 9e-08
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.23 2e-07
mRNA BRD-K78574327 CTRPv2 pan-cancer AAC 0.5 3e-07
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 4e-07
mRNA pifithrin-mu CTRPv2 pan-cancer AAC 0.19 6e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 9e-07
mRNA ABT-737 CTRPv2 pan-cancer AAC 0.21 1e-06
Download CSV